NASDAQ: AVIR       Atea Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
71.82   -1.95 (2.64%)  66.38 - 74.75  488,600


Avg Volume (4 weeks):270,550
4 Weeks Range:66.38 - 94.174
4 Weeks Price Volatility (%):
52 Weeks Range:24.15 - 94.174
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3207  6209  433  87 

Top 10 Active Counters
 RKT 41.60+17.30 
 SNDL 1.38+0.03 
 NIO 43.29-6.47 
 NNVC 6.65+2.43 
 SOS 6.80+0.11 
 F 12.55+0.57 
 AAPL 125.12-2.67 
 JCS 7.24+1.89 
 PBR 7.74-0.07 
 SPY 386.54-3.04